Tag: Molecular
Flare Therapeutics Presents Novel, AI-Based Method Identifying Luminal Subtype of Urothelial Cancer Supporting Lead Asset FX-909 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
– Approach has potential to identify patients likely to respond to PPARG inhibition through FX-909 –
– AI-powered, end-to-end learning model was deve [...]
1 / 1 POSTS